Vaughan David Investments’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Buy |
504,915
+12,182
| +2% | +$851K | 0.79% | 68 |
|
|
2025
Q1 | $36.2M | Buy |
492,733
+15,521
| +3% | +$1.14M | 0.85% | 65 |
|
|
2024
Q4 | $31.3M | Buy |
477,212
+31,784
| +7% | +$2.08M | 0.74% | 77 |
|
|
2024
Q3 | $34.7M | Buy |
445,428
+27,982
| +7% | +$2.18M | 0.8% | 74 |
|
|
2024
Q2 | $32.6M | Buy |
417,446
+36,685
| +10% | +$2.86M | 0.82% | 69 |
|
|
2024
Q1 | $25.8M | Buy |
+380,761
| New | +$25.8M | 0.64% | 83 |
|